The process of reducing GO with OA leads to a rapid removal of oxygen atoms from the graphene basal plane, thus allowing the modulation of the desired morphology (dendrites, nanosheets, and nanorods) [60]
Unlike natural amylin, which has a very short half-life, cagrilintide's molecular structure allows for once-weekly administration, making it considerably more practical for research applications
Anecdotally, some users report experiencing gastrointestinal issues like nausea, diarrhea, or constipation, as well as headache, fatigue, or irritation at the injection site
Proper technique reduces frequency, but occasional bruises are normal
GLP-1s offer a promising new tool in addressing this challenge, which is why physicians, patients, and policymakers are all paying close attention